Autoimmune Myocarditis, Old Dogs and New Tricks

Area of Science:

• Cardiology
• Immunology
• Pathogenesis of Myocarditis

Background:

• Autoimmunity is a key factor in myocarditis development, often seen in autoimmune diseases.
• Viral infections can also trigger myocarditis through immune dysregulation.
• Mechanisms driving myocarditis, including specific antigens and immune pathways, require further elucidation.

Purpose of the Study:

• To review current understanding of autoimmune mechanisms in myocarditis.
• To highlight the role of cardiac myosin-specific T cells in myocarditis pathogenesis.
• To discuss emerging therapies and future research directions.

Main Methods:

• Literature review of autoimmune myocarditis.
• Analysis of immune checkpoint inhibitor-associated myocarditis.
• Examination of T cell responses to cardiac myosin.

Main Results:

• Autoimmune responses, including T cells targeting cardiac myosin, are central to myocarditis.
• Immune checkpoint inhibitors can induce myocarditis via autoimmune mechanisms.
• Therapies targeting pathogenic T cells demonstrate efficacy in autoimmune myocarditis.

Conclusions:

• Understanding heart antigens, autoantibodies, and immune cells is crucial for myocarditis pathogenesis.
• Targeting autoreactive T cells offers a promising therapeutic strategy for autoimmune myocarditis.
• Further research is needed to refine clinical management and explore novel treatments.